Pre-order Enquiry
Request Free Sample
Global Cellular and Gene Therapy CDMO Market Research Report 2022
SKU ID : QYR-21765172 | Publishing Date : 22-Sep-2022 | No. of pages : 112
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Cellular and Gene Therapy CDMO Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Cell Therapy
1.2.3 Viral Vectors
1.2.4 Plasmid
1.3 Market by Application
1.3.1 Global Cellular and Gene Therapy CDMO Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cellular and Gene Therapy CDMO Market Perspective (2017-2028)
2.2 Cellular and Gene Therapy CDMO Growth Trends by Region
2.2.1 Cellular and Gene Therapy CDMO Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cellular and Gene Therapy CDMO Historic Market Size by Region (2017-2022)
2.2.3 Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2023-2028)
2.3 Cellular and Gene Therapy CDMO Market Dynamics
2.3.1 Cellular and Gene Therapy CDMO Industry Trends
2.3.2 Cellular and Gene Therapy CDMO Market Drivers
2.3.3 Cellular and Gene Therapy CDMO Market Challenges
2.3.4 Cellular and Gene Therapy CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular and Gene Therapy CDMO Players by Revenue
3.1.1 Global Top Cellular and Gene Therapy CDMO Players by Revenue (2017-2022)
3.1.2 Global Cellular and Gene Therapy CDMO Revenue Market Share by Players (2017-2022)
3.2 Global Cellular and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular and Gene Therapy CDMO Revenue
3.4 Global Cellular and Gene Therapy CDMO Market Concentration Ratio
3.4.1 Global Cellular and Gene Therapy CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular and Gene Therapy CDMO Revenue in 2021
3.5 Cellular and Gene Therapy CDMO Key Players Head office and Area Served
3.6 Key Players Cellular and Gene Therapy CDMO Product Solution and Service
3.7 Date of Enter into Cellular and Gene Therapy CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular and Gene Therapy CDMO Breakdown Data by Type
4.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Type (2017-2022)
4.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2023-2028)
5 Cellular and Gene Therapy CDMO Breakdown Data by Application
5.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Application (2017-2022)
5.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cellular and Gene Therapy CDMO Market Size (2017-2028)
6.2 North America Cellular and Gene Therapy CDMO Market Size by Country (2017-2022)
6.3 North America Cellular and Gene Therapy CDMO Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cellular and Gene Therapy CDMO Market Size (2017-2028)
7.2 Europe Cellular and Gene Therapy CDMO Market Size by Country (2017-2022)
7.3 Europe Cellular and Gene Therapy CDMO Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular and Gene Therapy CDMO Market Size (2017-2028)
8.2 Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Country (2017-2022)
8.3 Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cellular and Gene Therapy CDMO Market Size (2017-2028)
9.2 Latin America Cellular and Gene Therapy CDMO Market Size by Country (2017-2022)
9.3 Latin America Cellular and Gene Therapy CDMO Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular and Gene Therapy CDMO Market Size (2017-2028)
10.2 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2017-2022)
10.3 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Cellular and Gene Therapy CDMO Introduction
11.1.4 Catalent Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Cellular and Gene Therapy CDMO Introduction
11.2.4 Lonza Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.2.5 Lonza Recent Development
11.3 Charles River
11.3.1 Charles River Company Detail
11.3.2 Charles River Business Overview
11.3.3 Charles River Cellular and Gene Therapy CDMO Introduction
11.3.4 Charles River Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.3.5 Charles River Recent Development
11.4 The Discovery Labs
11.4.1 The Discovery Labs Company Detail
11.4.2 The Discovery Labs Business Overview
11.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Introduction
11.4.4 The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.4.5 The Discovery Labs Recent Development
11.5 BIOCENTRIQ
11.5.1 BIOCENTRIQ Company Detail
11.5.2 BIOCENTRIQ Business Overview
11.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Introduction
11.5.4 BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.5.5 BIOCENTRIQ Recent Development
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.7 Exothera
11.7.1 Exothera Company Detail
11.7.2 Exothera Business Overview
11.7.3 Exothera Cellular and Gene Therapy CDMO Introduction
11.7.4 Exothera Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.7.5 Exothera Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Detail
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Introduction
11.8.4 WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.8.5 WuXi AppTec Recent Development
11.9 Pharmaron
11.9.1 Pharmaron Company Detail
11.9.2 Pharmaron Business Overview
11.9.3 Pharmaron Cellular and Gene Therapy CDMO Introduction
11.9.4 Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.9.5 Pharmaron Recent Development
11.10 OBiO
11.10.1 OBiO Company Detail
11.10.2 OBiO Business Overview
11.10.3 OBiO Cellular and Gene Therapy CDMO Introduction
11.10.4 OBiO Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.10.5 OBiO Recent Development
11.11 Cell Therapies
11.11.1 Cell Therapies Company Detail
11.11.2 Cell Therapies Business Overview
11.11.3 Cell Therapies Cellular and Gene Therapy CDMO Introduction
11.11.4 Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.11.5 Cell Therapies Recent Development
11.12 AGC Biologics
11.12.1 AGC Biologics Company Detail
11.12.2 AGC Biologics Business Overview
11.12.3 AGC Biologics Cellular and Gene Therapy CDMO Introduction
11.12.4 AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.12.5 AGC Biologics Recent Development
11.13 Cytiva
11.13.1 Cytiva Company Detail
11.13.2 Cytiva Business Overview
11.13.3 Cytiva Cellular and Gene Therapy CDMO Introduction
11.13.4 Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.13.5 Cytiva Recent Development
11.14 Helixmith
11.14.1 Helixmith Company Detail
11.14.2 Helixmith Business Overview
11.14.3 Helixmith Cellular and Gene Therapy CDMO Introduction
11.14.4 Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.14.5 Helixmith Recent Development
11.15 ThermoGenesis
11.15.1 ThermoGenesis Company Detail
11.15.2 ThermoGenesis Business Overview
11.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Introduction
11.15.4 ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.15.5 ThermoGenesis Recent Development
11.16 Anemocyte
11.16.1 Anemocyte Company Detail
11.16.2 Anemocyte Business Overview
11.16.3 Anemocyte Cellular and Gene Therapy CDMO Introduction
11.16.4 Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.16.5 Anemocyte Recent Development
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Detail
11.17.2 Thermo Fisher Scientific Business Overview
11.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Introduction
11.17.4 Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.17.5 Thermo Fisher Scientific Recent Development
11.18 CBM
11.18.1 CBM Company Detail
11.18.2 CBM Business Overview
11.18.3 CBM Cellular and Gene Therapy CDMO Introduction
11.18.4 CBM Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.18.5 CBM Recent Development
11.19 Bio Elpida
11.19.1 Bio Elpida Company Detail
11.19.2 Bio Elpida Business Overview
11.19.3 Bio Elpida Cellular and Gene Therapy CDMO Introduction
11.19.4 Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.19.5 Bio Elpida Recent Development
11.20 Genezen
11.20.1 Genezen Company Detail
11.20.2 Genezen Business Overview
11.20.3 Genezen Cellular and Gene Therapy CDMO Introduction
11.20.4 Genezen Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.20.5 Genezen Recent Development
11.21 CCRM
11.21.1 CCRM Company Detail
11.21.2 CCRM Business Overview
11.21.3 CCRM Cellular and Gene Therapy CDMO Introduction
11.21.4 CCRM Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.21.5 CCRM Recent Development
11.22 RoslinCT
11.22.1 RoslinCT Company Detail
11.22.2 RoslinCT Business Overview
11.22.3 RoslinCT Cellular and Gene Therapy CDMO Introduction
11.22.4 RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.22.5 RoslinCT Recent Development
11.23 GenScript ProBio
11.23.1 GenScript ProBio Company Detail
11.23.2 GenScript ProBio Business Overview
11.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Introduction
11.23.4 GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.23.5 GenScript ProBio Recent Development
11.24 Oxford BioMedica
11.24.1 Oxford BioMedica Company Detail
11.24.2 Oxford BioMedica Business Overview
11.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Introduction
11.24.4 Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.24.5 Oxford BioMedica Recent Development
11.25 Porton Pharma Solutions
11.25.1 Porton Pharma Solutions Company Detail
11.25.2 Porton Pharma Solutions Business Overview
11.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Introduction
11.25.4 Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2017-2022)
11.25.5 Porton Pharma Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Cellular and Gene Therapy CDMO Market Research Report 2022
List of TablesTable 1. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Viral Vectors
Table 4. Key Players of Plasmid
Table 5. Global Cellular and Gene Therapy CDMO Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cellular and Gene Therapy CDMO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cellular and Gene Therapy CDMO Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cellular and Gene Therapy CDMO Market Share by Region (2017-2022)
Table 9. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cellular and Gene Therapy CDMO Market Share by Region (2023-2028)
Table 11. Cellular and Gene Therapy CDMO Market Trends
Table 12. Cellular and Gene Therapy CDMO Market Drivers
Table 13. Cellular and Gene Therapy CDMO Market Challenges
Table 14. Cellular and Gene Therapy CDMO Market Restraints
Table 15. Global Cellular and Gene Therapy CDMO Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cellular and Gene Therapy CDMO Market Share by Players (2017-2022)
Table 17. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2021)
Table 18. Ranking of Global Top Cellular and Gene Therapy CDMO Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cellular and Gene Therapy CDMO Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cellular and Gene Therapy CDMO Product Solution and Service
Table 22. Date of Enter into Cellular and Gene Therapy CDMO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cellular and Gene Therapy CDMO Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2017-2022)
Table 26. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2023-2028)
Table 28. Global Cellular and Gene Therapy CDMO Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2017-2022)
Table 30. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2023-2028)
Table 32. North America Cellular and Gene Therapy CDMO Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Cellular and Gene Therapy CDMO Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Cellular and Gene Therapy CDMO Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Cellular and Gene Therapy CDMO Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2023-2028) & (US$ Million)
Table 42. Catalent Company Detail
Table 43. Catalent Business Overview
Table 44. Catalent Cellular and Gene Therapy CDMO Product
Table 45. Catalent Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 46. Catalent Recent Development
Table 47. Lonza Company Detail
Table 48. Lonza Business Overview
Table 49. Lonza Cellular and Gene Therapy CDMO Product
Table 50. Lonza Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 51. Lonza Recent Development
Table 52. Charles River Company Detail
Table 53. Charles River Business Overview
Table 54. Charles River Cellular and Gene Therapy CDMO Product
Table 55. Charles River Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 56. Charles River Recent Development
Table 57. The Discovery Labs Company Detail
Table 58. The Discovery Labs Business Overview
Table 59. The Discovery Labs Cellular and Gene Therapy CDMO Product
Table 60. The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 61. The Discovery Labs Recent Development
Table 62. BIOCENTRIQ Company Detail
Table 63. BIOCENTRIQ Business Overview
Table 64. BIOCENTRIQ Cellular and Gene Therapy CDMO Product
Table 65. BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 66. BIOCENTRIQ Recent Development
Table 67. FUJIFILM Diosynth Biotechnologies Company Detail
Table 68. FUJIFILM Diosynth Biotechnologies Business Overview
Table 69. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product
Table 70. FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 71. FUJIFILM Diosynth Biotechnologies Recent Development
Table 72. Exothera Company Detail
Table 73. Exothera Business Overview
Table 74. Exothera Cellular and Gene Therapy CDMO Product
Table 75. Exothera Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 76. Exothera Recent Development
Table 77. WuXi AppTec Company Detail
Table 78. WuXi AppTec Business Overview
Table 79. WuXi AppTec Cellular and Gene Therapy CDMO Product
Table 80. WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 81. WuXi AppTec Recent Development
Table 82. Pharmaron Company Detail
Table 83. Pharmaron Business Overview
Table 84. Pharmaron Cellular and Gene Therapy CDMO Product
Table 85. Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 86. Pharmaron Recent Development
Table 87. OBiO Company Detail
Table 88. OBiO Business Overview
Table 89. OBiO Cellular and Gene Therapy CDMO Product
Table 90. OBiO Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 91. OBiO Recent Development
Table 92. Cell Therapies Company Detail
Table 93. Cell Therapies Business Overview
Table 94. Cell Therapies Cellular and Gene Therapy CDMOProduct
Table 95. Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 96. Cell Therapies Recent Development
Table 97. AGC Biologics Company Detail
Table 98. AGC Biologics Business Overview
Table 99. AGC Biologics Cellular and Gene Therapy CDMOProduct
Table 100. AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 101. AGC Biologics Recent Development
Table 102. Cytiva Company Detail
Table 103. Cytiva Business Overview
Table 104. Cytiva Cellular and Gene Therapy CDMOProduct
Table 105. Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 106. Cytiva Recent Development
Table 107. Helixmith Company Detail
Table 108. Helixmith Business Overview
Table 109. Helixmith Cellular and Gene Therapy CDMOProduct
Table 110. Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 111. Helixmith Recent Development
Table 112. ThermoGenesis Company Detail
Table 113. ThermoGenesis Business Overview
Table 114. ThermoGenesis Cellular and Gene Therapy CDMOProduct
Table 115. ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 116. ThermoGenesis Recent Development
Table 117. Anemocyte Company Detail
Table 118. Anemocyte Business Overview
Table 119. Anemocyte Cellular and Gene Therapy CDMOProduct
Table 120. Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 121. Anemocyte Recent Development
Table 122. Thermo Fisher Scientific Company Detail
Table 123. Thermo Fisher Scientific Business Overview
Table 124. Thermo Fisher Scientific Cellular and Gene Therapy CDMOProduct
Table 125. Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 126. Thermo Fisher Scientific Recent Development
Table 127. CBM Company Detail
Table 128. CBM Business Overview
Table 129. CBM Cellular and Gene Therapy CDMOProduct
Table 130. CBM Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 131. CBM Recent Development
Table 132. Bio Elpida Company Detail
Table 133. Bio Elpida Business Overview
Table 134. Bio Elpida Cellular and Gene Therapy CDMOProduct
Table 135. Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 136. Bio Elpida Recent Development
Table 137. Genezen Company Detail
Table 138. Genezen Business Overview
Table 139. Genezen Cellular and Gene Therapy CDMOProduct
Table 140. Genezen Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 141. Genezen Recent Development
Table 142. CCRM Company Detail
Table 143. CCRM Business Overview
Table 144. CCRM Cellular and Gene Therapy CDMOProduct
Table 145. CCRM Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 146. CCRM Recent Development
Table 147. RoslinCT Company Detail
Table 148. RoslinCT Business Overview
Table 149. RoslinCT Cellular and Gene Therapy CDMOProduct
Table 150. RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 151. RoslinCT Recent Development
Table 152. GenScript ProBio Company Detail
Table 153. GenScript ProBio Business Overview
Table 154. GenScript ProBio Cellular and Gene Therapy CDMOProduct
Table 155. GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 156. GenScript ProBio Recent Development
Table 157. Oxford BioMedica Company Detail
Table 158. Oxford BioMedica Business Overview
Table 159. Oxford BioMedica Cellular and Gene Therapy CDMOProduct
Table 160. Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 161. Oxford BioMedica Recent Development
Table 162. Porton Pharma Solutions Company Detail
Table 163. Porton Pharma Solutions Business Overview
Table 164. Porton Pharma Solutions Cellular and Gene Therapy CDMOProduct
Table 165. Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2017-2022) & (US$ Million)
Table 166. Porton Pharma Solutions Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cellular and Gene Therapy CDMO Market Share by Type: 2021 VS 2028
Figure 2. Cell Therapy Features
Figure 3. Viral Vectors Features
Figure 4. Plasmid Features
Figure 5. Global Cellular and Gene Therapy CDMO Market Share by Application in 2021 & 2028
Figure 6. Commercial Case Studies
Figure 7. Academic Research Case Studies
Figure 8. Others Case Studies
Figure 9. Cellular and Gene Therapy CDMO Report Years Considered
Figure 10. Global Cellular and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Cellular and Gene Therapy CDMO Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Cellular and Gene Therapy CDMO Market Share by Region: 2021 VS 2028
Figure 13. Global Cellular and Gene Therapy CDMO Market Share by Players in 2021
Figure 14. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Cellular and Gene Therapy CDMO Revenue in 2021
Figure 16. North America Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Cellular and Gene Therapy CDMO Market Share by Country (2017-2028)
Figure 18. United States Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Cellular and Gene Therapy CDMO Market Share by Country (2017-2028)
Figure 22. Germany Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Cellular and Gene Therapy CDMO Market Share by Region (2017-2028)
Figure 30. China Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Cellular and Gene Therapy CDMO Market Share by Country (2017-2028)
Figure 38. Mexico Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Cellular and Gene Therapy CDMO Market Share by Country (2017-2028)
Figure 42. Turkey Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Cellular and Gene Therapy CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Catalent Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 45. Lonza Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 46. Charles River Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 47. The Discovery Labs Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 48. BIOCENTRIQ Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 49. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 50. Exothera Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 51. WuXi AppTec Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 52. Pharmaron Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 53. OBiO Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 54. Cell Therapies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 55. AGC Biologics Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 56. Cytiva Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 57. Helixmith Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 58. ThermoGenesis Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 59. Anemocyte Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 61. CBM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 62. Bio Elpida Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 63. Genezen Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 64. CCRM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 65. RoslinCT Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 66. GenScript ProBio Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 67. Oxford BioMedica Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 68. Porton Pharma Solutions Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Keyplayers in Global Cellular and Gene Therapy CDMO Market Research Report 2022
CatalentLonza
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
